Gary Patou sold $70K of XENE stock

Gary Patou, Dir of Xenon Pharmaceuticals Inc. (XENE), sold 1,322 shares of XENE stock worth $70K, per an SEC Form 4 filed Jun 8, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jun 5, 2026, 3 days before it was made public.

XENE has moved -20.8% since the trade date, from $51.73 to $40.99 (Nov 12, 2026 close).